Quick Overview
- 1#1: Phoenix NLME - Industry-leading platform for nonlinear mixed-effects modeling in population PK/PD analysis.
- 2#2: NONMEM - Gold standard software for advanced population pharmacokinetic and pharmacodynamic modeling.
- 3#3: Monolix - User-friendly suite for stochastic approximation EM-based population PK/PD modeling.
- 4#4: nlmixr2 - Open-source R package for flexible nonlinear mixed-effects PK/PD modeling.
- 5#5: GastroPlus - Comprehensive PBPK/PD modeling platform for ADME predictions and simulations.
- 6#6: Simcyp Simulator - Population-based PBPK platform for predicting drug metabolism and DDI risks.
- 7#7: PK-Sim - Open-source tool for multi-scale physiologically-based PK modeling.
- 8#8: SimBiology - MATLAB toolbox for quantitative systems pharmacology and PK/PD modeling.
- 9#9: mrgsolve - R package for efficient simulation from nonlinear mixed-effects PK models.
- 10#10: Berkeley Madonna - High-performance numerical solver for ordinary differential equations in PK modeling.
We assessed tools based on technical excellence, suitability for diverse use cases (including nonlinear mixed-effects modeling, PBPK simulations, and systems pharmacology), user experience, and long-term value, prioritizing reliability and adaptability to modern drug development demands.
Comparison Table
This comparison table examines leading PK modeling software tools, including Phoenix NLME, NONMEM, Monolix, nlmixr2, GastroPlus, and more, to highlight their unique features and functionalities. Readers will discover key differences in workflow, capabilities, and suitability for various use cases to inform their software selection.
| # | Tool | Category | Overall | Features | Ease of Use | Value |
|---|---|---|---|---|---|---|
| 1 | Phoenix NLME Industry-leading platform for nonlinear mixed-effects modeling in population PK/PD analysis. | enterprise | 9.7/10 | 9.9/10 | 7.2/10 | 8.8/10 |
| 2 | NONMEM Gold standard software for advanced population pharmacokinetic and pharmacodynamic modeling. | enterprise | 9.4/10 | 9.8/10 | 5.8/10 | 8.2/10 |
| 3 | Monolix User-friendly suite for stochastic approximation EM-based population PK/PD modeling. | specialized | 8.7/10 | 9.2/10 | 8.0/10 | 7.8/10 |
| 4 | nlmixr2 Open-source R package for flexible nonlinear mixed-effects PK/PD modeling. | specialized | 8.7/10 | 9.2/10 | 7.1/10 | 10.0/10 |
| 5 | GastroPlus Comprehensive PBPK/PD modeling platform for ADME predictions and simulations. | enterprise | 8.5/10 | 9.2/10 | 7.8/10 | 8.0/10 |
| 6 | Simcyp Simulator Population-based PBPK platform for predicting drug metabolism and DDI risks. | enterprise | 8.7/10 | 9.4/10 | 7.2/10 | 8.1/10 |
| 7 | PK-Sim Open-source tool for multi-scale physiologically-based PK modeling. | specialized | 8.4/10 | 9.2/10 | 7.6/10 | 9.7/10 |
| 8 | SimBiology MATLAB toolbox for quantitative systems pharmacology and PK/PD modeling. | specialized | 7.8/10 | 8.5/10 | 6.0/10 | 7.0/10 |
| 9 | mrgsolve R package for efficient simulation from nonlinear mixed-effects PK models. | specialized | 8.3/10 | 9.2/10 | 7.1/10 | 10/10 |
| 10 | Berkeley Madonna High-performance numerical solver for ordinary differential equations in PK modeling. | other | 7.5/10 | 7.2/10 | 8.8/10 | 8.5/10 |
Industry-leading platform for nonlinear mixed-effects modeling in population PK/PD analysis.
Gold standard software for advanced population pharmacokinetic and pharmacodynamic modeling.
User-friendly suite for stochastic approximation EM-based population PK/PD modeling.
Open-source R package for flexible nonlinear mixed-effects PK/PD modeling.
Comprehensive PBPK/PD modeling platform for ADME predictions and simulations.
Population-based PBPK platform for predicting drug metabolism and DDI risks.
Open-source tool for multi-scale physiologically-based PK modeling.
MATLAB toolbox for quantitative systems pharmacology and PK/PD modeling.
R package for efficient simulation from nonlinear mixed-effects PK models.
High-performance numerical solver for ordinary differential equations in PK modeling.
Phoenix NLME
enterpriseIndustry-leading platform for nonlinear mixed-effects modeling in population PK/PD analysis.
Its proprietary NLME solver with first-order conditional estimation (FOCE) and Bayesian methods, delivering unmatched speed and robustness for the most challenging hierarchical models.
Phoenix NLME, developed by Certara, is a premier nonlinear mixed-effects (NLME) modeling software designed for advanced pharmacokinetics (PK) and pharmacodynamics (PD) analysis in drug development. It excels in population modeling, handling complex hierarchical models with sparse data from clinical trials to estimate fixed and random effects, variability, and covariates. The tool supports Bayesian and frequentist approaches, model diagnostics, and simulation for optimal dosing strategies, making it a cornerstone for regulatory submissions.
Pros
- Exceptionally powerful NLME engine for handling massive datasets and complex models with high precision
- Advanced diagnostics, visualization, and simulation capabilities tailored for PK/PD workflows
- Validated for regulatory use with seamless integration into Phoenix suite (e.g., WinNonlin)
Cons
- Steep learning curve requiring pharmacometrics expertise
- High computational demands, especially for large simulations
- Premium pricing limits accessibility for small teams or academics
Best For
Experienced pharmacometricians and pharmaceutical R&D teams needing top-tier population PK/PD modeling for clinical trials and regulatory filings.
Pricing
Enterprise licensing model; annual subscriptions start at ~$10,000+ per user, with volume discounts and custom quotes available from Certara.
NONMEM
enterpriseGold standard software for advanced population pharmacokinetic and pharmacodynamic modeling.
FOCE with Interaction method for superior bias reduction in variance-covariance estimation
NONMEM, developed by ICON plc, is a cornerstone software for nonlinear mixed-effects modeling (NLME) in population pharmacokinetics (PK) and pharmacodynamics (PD). It excels at analyzing sparse and complex datasets from clinical trials using advanced estimation methods like FOCE, Laplace, and SAEM. Widely adopted in the pharmaceutical industry, it supports model-based drug development and regulatory submissions with high precision and flexibility.
Pros
- Gold standard accuracy for population PK/PD modeling
- Robust handling of large, unbalanced datasets
- Extensive library of estimation algorithms including FOCE-INTERACTION
Cons
- Steep learning curve due to control stream syntax
- Limited graphical user interface; primarily command-line driven
- High licensing costs with no free version
Best For
Experienced pharmacometricians in pharma R&D teams handling complex regulatory PK modeling.
Pricing
Enterprise licensing model; pricing upon request from ICON plc, typically $10,000+ annually per seat or site-based depending on scale.
Monolix
specializedUser-friendly suite for stochastic approximation EM-based population PK/PD modeling.
Proprietary Stochastic Approximation Expectation-Maximization (SAEM) algorithm for superior convergence speed and accuracy in NLME estimation
Monolix, developed by Lixoft (lixoft.com), is a leading software for nonlinear mixed-effects modeling (NLME) in population pharmacokinetics (PK) and pharmacodynamics (PD). It excels in parameter estimation, model diagnostics, simulation via Mlxplore, and visualization tools tailored for drug development workflows. Integrated with R through mlxR, it supports complex models including stochastic differential equations and is widely used in pharma R&D.
Pros
- Highly efficient SAEM algorithm for fast and robust parameter estimation even with sparse data
- User-friendly GUI with drag-and-drop model building and rich diagnostics
- Seamless integration with R and extensive library of PK/PD models
Cons
- Steeper learning curve for users new to NLME concepts
- Limited built-in support for non-compartmental analysis (NCA) compared to competitors
- High commercial licensing costs may deter small teams or academics without discounts
Best For
Experienced pharmacometricians in pharmaceutical companies handling complex population PK/PD modeling during drug development.
Pricing
Commercial annual subscriptions start at ~€5,000/user; academic and trial licenses available at reduced rates.
nlmixr2
specializedOpen-source R package for flexible nonlinear mixed-effects PK/PD modeling.
Intuitive event-based model syntax that mimics mathematical PK equations for rapid prototyping of complex dosing regimens and covariates
nlmixr2 is an open-source R package for nonlinear mixed-effects (NLME) modeling, primarily used in pharmacometrics for population PK/PD analysis. It leverages the rxode2 engine for fast ODE solving and simulation, supporting estimation methods like FOCEi, SAEM, and Bayesian via brms or Stan. The package enables building complex compartmental models, handling event-based dosing, and integrating seamlessly with the R ecosystem for data processing and visualization.
Pros
- Extremely powerful for advanced NLME PK/PD modeling with multiple estimation algorithms
- Lightning-fast ODE solving and simulation via rxode2 integration
- Free, open-source, and highly extensible within R/tidyverse workflows
Cons
- Steep learning curve requiring solid R programming skills
- Model specification syntax can be tricky for beginners
- Limited GUI; relies heavily on command-line scripting
Best For
Experienced R users and pharmacometricians seeking customizable, high-performance population PK modeling without commercial software costs.
Pricing
Free (open-source R package)
GastroPlus
enterpriseComprehensive PBPK/PD modeling platform for ADME predictions and simulations.
Proprietary ACAT™ model for mechanistic simulation of gastrointestinal absorption and transit
GastroPlus, developed by Simulations Plus, is a physiologically-based pharmacokinetic (PBPK) modeling software specialized in predicting drug absorption, distribution, metabolism, and excretion (ADME), particularly for oral bioavailability. It uses advanced compartmental absorption and transit (ACAT) models integrated with human physiology to simulate PK profiles from preclinical data. The tool supports de-risking drug development by enabling in silico predictions validated against extensive clinical datasets.
Pros
- Sophisticated PBPK and ACAT models for accurate GI absorption predictions
- Extensive library of physiological data and validation against clinical trials
- Powerful visualization and reporting tools for PK simulations
Cons
- Steep learning curve for non-experts due to complex modeling options
- High licensing costs limit accessibility for small teams or academics
- Primarily focused on absorption/PK, less emphasis on advanced systems pharmacology
Best For
Pharmaceutical R&D teams in drug discovery and development requiring precise PBPK simulations for oral drug candidates.
Pricing
Enterprise licensing model; annual subscriptions typically range from $20,000+ USD per user/seat, with custom quotes required.
Simcyp Simulator
enterprisePopulation-based PBPK platform for predicting drug metabolism and DDI risks.
Advanced population simulator with ontogeny, ethnicity, and disease-specific virtual populations for highly realistic variability modeling
Simcyp Simulator, developed by Certara, is a population-based physiologically-based pharmacokinetic (PBPK) modeling platform used for predicting drug absorption, distribution, metabolism, and excretion (ADME) in virtual populations. It supports drug development by integrating extensive libraries of compounds, enzymes, transporters, and demographic data to simulate clinical outcomes and assess drug-drug interactions. The software is widely used in pharmaceutical R&D for regulatory submissions and optimizing clinical trial designs.
Pros
- Comprehensive PBPK modeling with built-in libraries of over 1,000 compounds and physiological parameters
- Strong support for population variability and drug-drug interaction predictions
- High regulatory acceptance by FDA, EMA, and other agencies
Cons
- Steep learning curve requiring expertise in pharmacokinetics
- High computational demands and resource-intensive simulations
- Enterprise-level pricing not suitable for small teams or academics
Best For
Large pharmaceutical companies and research teams needing advanced PBPK simulations for population-based drug predictions and regulatory filings.
Pricing
Enterprise licensing model; pricing available upon request from Certara, typically starting in the tens of thousands annually for commercial use.
PK-Sim
specializedOpen-source tool for multi-scale physiologically-based PK modeling.
Sophisticated physiologically-based models accounting for organ-level details, population variability, and life-stage changes like pediatrics and geriatrics
PK-Sim, part of the Open Systems Pharmacology suite, is an open-source tool specialized in physiologically-based pharmacokinetic (PBPK) modeling for simulating drug absorption, distribution, metabolism, and excretion (ADME) in virtual human populations. It offers detailed anatomical and physiological models, supporting variations by age, sex, ethnicity, disease states, and ontogeny. Users can build complex simulations using a modular building-block interface and integrate with MoBi for PK/PD analysis.
Pros
- Free and open-source with no licensing costs
- Advanced PBPK capabilities including population simulations and ontogeny models
- Modular building-block interface for flexible model construction
Cons
- Steep learning curve for users new to PBPK modeling
- Requires significant computational resources for large simulations
- Community-driven support lacks the immediacy of commercial vendors
Best For
Academic researchers and pharmacokinetic modelers focused on PBPK simulations in diverse virtual populations.
Pricing
Completely free as open-source software.
SimBiology
specializedMATLAB toolbox for quantitative systems pharmacology and PK/PD modeling.
Graphical model builder for intuitive construction of biological reaction networks with PK compartments
SimBiology is a MATLAB toolbox from MathWorks specialized in mechanistic modeling of biological systems, with robust support for pharmacokinetics (PK) and pharmacodynamics (PD) simulations. It enables users to construct complex compartmental models, perform parameter estimation, sensitivity analysis, and optimal design using both graphical and programmatic interfaces. Ideal for systems pharmacology, it handles deterministic and stochastic simulations while integrating seamlessly with MATLAB's ecosystem for advanced data analysis.
Pros
- Highly flexible for building custom mechanistic PK/PD models
- Advanced simulation capabilities including ODEs, SDEs, and parameter estimation
- Deep integration with MATLAB toolboxes for optimization and visualization
Cons
- Steep learning curve requiring MATLAB proficiency
- Expensive licensing model tied to MATLAB
- Less intuitive GUI compared to dedicated standalone PK software
Best For
Experienced modelers in pharma R&D comfortable with programming who need customizable, complex PK systems modeling.
Pricing
MATLAB toolbox add-on; commercial perpetual license ~$2,500 + maintenance, or annual subscription ~$1,200+, with academic discounts.
mrgsolve
specializedR package for efficient simulation from nonlinear mixed-effects PK models.
Compiled C++ solver delivering unmatched speed for simulating thousands of virtual subjects in seconds
mrgsolve is an open-source R package specialized for fast simulation of pharmacokinetic/pharmacodynamic (PK/PD) models in pharmacometrics. Users define models using a concise, C++-inspired syntax that compiles to highly efficient code, enabling rapid simulations of large populations. It excels in handling complex ODE-based models, dosing events, covariates, and integration with R's data analysis ecosystem for tasks like trial simulation and posterior predictive checks.
Pros
- Blazing-fast simulation speeds for large-scale population PK/PD analyses
- Flexible model syntax supporting advanced features like time-varying covariates and nested compartments
- Deep integration with R/tidyverse for seamless data handling and visualization
Cons
- Steep learning curve for the model specification syntax without prior pharmacometrics experience
- Focused on simulation rather than parameter estimation or full model fitting
- No graphical user interface; requires R programming proficiency
Best For
Experienced R users and pharmacometricians focused on efficient PK/PD model simulation and diagnostics.
Pricing
Completely free and open-source under GPL license.
Berkeley Madonna
otherHigh-performance numerical solver for ordinary differential equations in PK modeling.
Proprietary high-speed stiff ODE integrators that simulate complex PK models in seconds
Berkeley Madonna is a specialized numerical modeling software for solving ordinary differential equations (ODEs), widely used in pharmacokinetics (PK) for simulating compartmental models and predicting drug concentration-time profiles. It supports rapid prototyping of PK models with tools for parameter fitting, sensitivity analysis, and bifurcation diagrams. While powerful for deterministic simulations, it is less suited for advanced population PK or nonlinear mixed-effects modeling compared to dedicated tools.
Pros
- Extremely fast ODE solvers for quick simulations of stiff PK systems
- Intuitive graphical interface for model building and visualization
- Built-in optimization and sensitivity analysis tools
Cons
- No native support for population PK or NLME modeling
- Limited PK-specific libraries and data import/export options
- Windows-only with a somewhat dated user interface
Best For
Individual researchers, students, and educators needing fast prototyping and simulation of basic to intermediate deterministic PK models.
Pricing
Personal edition starts at $195; Professional at $795; academic and site licenses available with discounts.
Conclusion
Among the top PK modeling tools, Phoenix NLME leads as the top choice, boasting industry-leading capabilities for nonlinear mixed-effects analysis. NONMEM, the longstanding gold standard, excels for advanced use, while Monolix impresses with its user-friendly stochastic approximation EM-based approach. Each tool suits unique needs, but Phoenix NLME stands out for comprehensive performance.
Explore Phoenix NLME to unlock efficient, accurate population PK/PD modeling and take your analyses to the next level.
Tools Reviewed
All tools were independently evaluated for this comparison
Referenced in the comparison table and product reviews above.